Related Experiment Videos
HLA-antigen in the differential diagnosis of the Raynaud-phenomenon
VASA. Zeitschrift Fur Gefasskrankheiten
|January 1, 1982
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Functional vascular diseases: Raynaud's syndrome, acrocyanosis and erythromelalgia.
VASA. Zeitschrift fur Gefasskrankheiten·2010
Lithium niobate guided-wave network for a coherent receiver.
Optics letters·2009
Asymptomatic venous thrombosis in cancer patients--a problem often overlooked. Results of a retrospective and prospective study.
VASA. Zeitschrift fur Gefasskrankheiten·2009
[15 years Amputierten-Initiative e.V].
VASA. Zeitschrift fur Gefasskrankheiten·2009
Circulating nerve growth factor in primary and secondary Raynaud's syndrome - results of a pilot study.
VASA. Zeitschrift fur Gefasskrankheiten·2009
Long-term clinical outcomes of self-expandable closed-cell and open-cell stents for endovascular reconstruction of the inferior vena cava.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Atherectomy, scoring and drug-coated balloon angioplasty for atherosclerotic common femoral artery disease - A two center study.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Mid-term results of orbital atherectomy in heavily calcified lesions above and below the knee.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Hospital incidence, treatment and mortality of traumatic aortic injury in German hospitals.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Vascular medicine in older adults - A call for structured cooperation to improve care.
VASA. Zeitschrift fur Gefasskrankheiten·2026
2-Year outcomes of endovascular therapy of popliteal artery restenosis.
VASA. Zeitschrift fur Gefasskrankheiten·2026
Prolonged low-dose intravenous thrombolysis in early recurrent stroke.
Neurologia i neurochirurgia polska·2026
HBsAg seroclearance with HBV DNA <100 IU/mL and long-term risks of adverse liver events, all-cause mortality, and cause-specific mortality in chronic hepatitis B: a prospective cohort study.
The Lancet regional health. Western Pacific·2026
Cost-effectiveness and budget impact of Luspatercept in Thai adults with transfusion-dependent beta-thalassaemia: a multi-state Markov model based on national claims data.
Journal of pharmaceutical policy and practice·2026